Biomechanics and gene expression in abdominal aortic aneurysm

Journal of Vascular Surgery

Volumn 60, Issue 6, 2014, Pages 1640-1647.e2

  Reeps, Christian ^a   Kehl, Sebastian ^b   Tanios, Fadwa ^a   Biehler, Jonas ^a   Pelisek, Jaroslav ^a   Wall, Wolfgang A ^a   Eckstein, Hans Henning ^a   Gee, Michael W ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Mechanics and High Performance Computing Group   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; GELATINASE A; GELATINASE B; MACROPHAGE SCAVENGER RECEPTOR 1; MESSENGER RNA; SCAVENGER RECEPTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG; GENETIC MARKER;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ANEURYSM SURGERY; ARTERIAL STIFFNESS; ARTERY WALL; ARTICLE; BIOMECHANICS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FINITE ELEMENT ANALYSIS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRESS STRAIN RELATIONSHIP; TENSILE STRENGTH; WALL STRESS; ABDOMINAL AORTA; AORTOGRAPHY; BIOLOGICAL MODEL; CHEMISTRY; COMPUTER SIMULATION; GENE EXPRESSION REGULATION; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; MECHANICAL STRESS; MIDDLE AGED; PATHOPHYSIOLOGY; PHENOTYPE; PROCEDURES; RADIOGRAPHY; VASCULAR REMODELING; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; AORTOGRAPHY; BIOMECHANICAL PHENOMENA; COMPUTER SIMULATION; FEMALE; FINITE ELEMENT ANALYSIS; GENE EXPRESSION REGULATION; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STRESS, MECHANICAL; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR REMODELING;

EID: 84925225954     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2014.08.076     Document Type: Article

References (40)

1. Hellenthal FA, Buurman WA, Wodzig WK, Schurink GW. Biomarkers of AAA progression. Part 1: extracellular matrix degeneration. Nat Rev Cardiol 2009;6:464-74.
2. Menashi S, Campa JS, Greenhalgh RM, Powell JT. Collagen in abdominal aortic aneurysm: typing, content, and degradation. J Vasc Surg 1987;6:578-82.
3. Raghavan ML, Vorp DA. Toward a biomechanical tool to evaluate rupture potential of abdominal aortic aneurysm: identification of a finite strain constitutive model and evaluation of its applicability. J Biomech 2000;33:475-82.
4. Marini G, Maier A, Reeps C, Eckstein HH, Wall WA, Gee MW. A continuum description of the damage process in the arterial wall of abdominal aortic aneurysms. Int J Numer Methods Biomed Eng 2012;28:87-99.
5. Reeps C, Maier A, Pelisek J, Hartl F, Grabher-Meier V, Wall WA, et al. Measuring and modeling patient-specific distributions of material properties in abdominal aortic aneurysm wall. Biomech Model Mechanobiol 2013;12:717-33.
6. Okamoto RJ, Wagenseil JE, DeLong WR, Peterson SJ, Kouchoukos NT, Sundt TM 3rd. Mechanical properties of dilated human ascending aorta. Ann Biomed Eng 2002;30:624-35.
7. Van de Geest JP, Sacks MS, Vorp DA. The effects of aneurysm on the biaxial mechanical behavior of human abdominal aorta. J Biomech 2006;39:1324-34.
8. Rizzo RJ, McCarthy WJ, Dixit SN, Lilly MP, Shively VP, Flinn WR, et al. Collagen types and matrix protein content in human abdominal aortic aneurysms. J Vasc Surg 1989;10:365-73.
9. Keeling WB, Armstrong PA, Stone PA, Bandyk DF, Shames ML. An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms. Vasc Endovascular Surg 2005;39:457-64.
10. Thompson M, Cockerill G. Matrix metalloproteinase-2. The forgotten enzyme in aneurysm pathogenesis. Ann N Y Acad Sci 2006;1085:170-4.
11. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 2002;110:625-32.
12. Choke E, Cockerill G, Wilson WR, Sayed S, Dawson J, Loftus I, et al. A review of biological factors implicated in abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg 2005;30:227-44.
13. Tamarina NA, McMillan WD, Shively VP, Pearce WH. Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. Surgery 1997;122:264-72.
14. Yamashita A, Noma T, Nakazawa A, Saito S, Fujioka K, Zempo N, et al. Enhanced expression of matrix metalloproteinase-9 in abdominal aortic aneurysms. World J Surg 2001;25:259-65.
15. Reeps C, Pelisek J, Seidl S, Schuster T, Zimmermann A, Kuehnl A, et al. Inflammatory infiltrates and neovessels are relevant sources of MMPs in abdominal aortic aneurysm wall. Pathobiology 2009;76:243-52.
16. Hellenthal FA, Geenen IL, Teijink JA, Heeneman S, Schurink GW. Histological features of human abdominal aortic aneurysm are not related to clinical characteristics. Cardiovasc Pathol 2009;18:286-93.
17. Shimizu K, Libby P, Mitchell RN. Local cytokine environments drive aneurysm formation in allografted aortas. Trends Cardiovasc Med 2005;15:142-8.
18. Gasser TC, Auer M, Labruto F, Swedenborg J, Roy J. Biomechanical rupture risk assessment of abdominal aortic aneurysms: model complexity versus predictability of finite element simulations. Eur J Vasc Endovasc Surg 2010;40:176-85.
19. Maier A, Gee MW, Reeps C, Pongratz J, Eckstein HH, Wall WA. A comparison of diameter, wall stress, and rupture potential index for abdominal aortic aneurysm rupture risk prediction. Ann Biomed Eng 2010;38:3124-34.
20. Raghavan ML, Fillinger MF, Marra SP, Naegelein BP, Kennedy FE. Automated methodology for determination of stress distribution in human abdominal aortic aneurysm. J Biochem Eng 2005;127:868-71.
21. Rausch SM, Martin C, Bornemann PB, Uhlig S, Wall WA. Material model of lung parenchyma based on living precision-cut lung slice testing. J Mech Behav Biomed Mater 2011;4:583-92.
22. Lee SM, Schelcher C, Gashi S, Schreiber S, Thasler RM, Jauch KW, et al. RNA stability in human liver: comparison of different processing times, temperatures and methods. Mol Biotechnol 2013;53:1-8.
23. Chandana R, Mythri RB, Mahadevan A, Shankar SK, Srinivas Bharath MM. Biochemical analysis of protein stability in human brain collected at different post-mortem intervals. Indian J Med Res 2009;129:189-99.
24. Wall WA, Gee MW. BACIda multiphysics simulation environment. Technical report, Technische Universität München; 2014.
25. Gasser TC, Görgülü G, Folkesson M, Swedenborg J. Failure properties of intraluminal thrombus in abdominal aortic aneurysm under static and pulsating mechanical loads. J Vasc Surg 2008;48:179-88.
26. Mayne R. Collagenous proteins of blood vessels. Arteriosclerosis 1986;6:585-93.
27. van der Rest M, Garrone R. Collagen family of proteins. FASEB J 1991;5:2814-23.
28. Jacob MP. Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions. Biomed Pharmacother 2003;57:195-202.
29. Sakalihasan N, Limet R, Defawe OD. Abdominal aortic aneurysm. Lancet 2005;365:1577-89.
30. Lindholt JS, Shi GP. Chronic inflammation, immune response, and infection in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2006;31:453-63.
31. Dwivedi RS, Herman JG, McCaffrey TA, Raj DS. Beyond genetics: epigenetic code in chronic kidney disease. Kidney Int 2011;79:23-32.
32. Kitada M, Zhang Z, Mima A, King GL. Molecular mechanisms of diabetic vascular complications. J Diabetes Investig 2010;1:77-89.
33. Chatzizisis YS, Coskun AU, Jonas M, Edelman ER, Feldman CL, Stone PH. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J Am Coll Cardiol 2007;49:2379-93.
34. Culav EM, Clark CH, Merrilees MJ. Connective tissues: matrix composition and its relevance to physical therapy. Phys Ther 1999;79:308-19.
35. Dilmé JF, Bellmunt S, Camacho M, Solà-Villà D, Romero JM, Escudero JR, et al. Influence of cardiovascular risk factors on levels of matrix metalloproteinases 2 and 9 in human abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2014;48:374-81.
36. Papalambros E, Sigala F, Georgopoulos S, Menekakos C, Giatromanolaki A, Bastounis E, et al. Immunohistochemical expression of metalloproteinases MMP-2 and MMP-9 in abdominal aortic aneurysms: correlation with symptoms and aortic diameter. Int J Mol Med 2003;12:965-8.
37. Petersen E, Wågberg F, Angquist KA. Proteolysis of the abdominal aortic aneurysm wall and the association with rupture. Eur J Vasc Endovasc Surg 2002;23:153-7.
38. Lauhio A, Hästbacka J, Pettilä V, Tervahartiala T, Karlsson S, Varpula T, et al. Serum MMP-8, -9 and TIMP-1 in sepsis: high serum levels of MMP-8 and TIMP-1 are associated with fatal outcome in a multicentre, prospective cohort study. Hypothetical impact of tetracyclines. Pharmacol Res 2011;64:590-4.
39. Flondell-Sité D, Lindblad B, Kölbel T, Gottsäter A. Markers of proteolysis, fibrinolysis, and coagulation in relation to size and growth rate of abdominal aortic aneurysms. Vasc Endovascular Surg 2010;44:262-8.
40. Hurks R, Pasterkamp G, Vink A, Hoefer IE, Bots ML, van de Pavoordt HD, et al. Circumferential heterogeneity in the abdominal aortic aneurysm wall composition suggests lateral sides to be more rupture prone. J Vasc Surg 2012;55:203-9.